Oxalis Labs is a finished-dose manufacturer based in India. It appears in 6 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with CDSCO (India) and NAFDAC (NG). Its GMP standing is certified by US FDA, NCELS (KZ) and FDA (GH), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 2 June 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Solan, India | 3010868532 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 3 | None |
| NAFDAC (NG) | 3 | 1 |
| US FDA | None | 1 |
| NCELS (KZ) | None | 1 |
| FDA (GH) | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Oxalis Labs comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.